H-Chg-OH

Catalog No. :
ACWMHB495
CAS No. :
14328-51-9
Molecular Formula :
C8H15NO2
Molecular Weight :
157.21

IUPAC Name:(S)-2-amino-2-cyclohexylacetic acid

H-Chg-OH structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
500g97%$208.00Login to see priceIn stockInquiry
1000g97%$415.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameH-Chg-OH
IUPAC Name(S)-2-amino-2-cyclohexylacetic acid
MDL No.MFCD01311679
Molecular FormulaC8H15NO2
Molecular Weight157.21
SMILESO=C(O)[C@@H](N)C1CCCCC1
InChI KeyWAMWSIDTKSNDCU-ZETCQYMHSA-N
SynonymH-Chg-OH | (2S)-amino(cyclohexyl)ethanoic acid | 59Q5O5615E | (S)aminocyclohexylacetic acid | L-(+)-2-Cyclohexylglycine | Cyclohexylglycine, (S)- | AC-1917 | 2-Cyclohexyl-L-glycine | BDBM50179712 | CS-M1867 | L-2-Cyclohexylglycine | GS-3339 | (s)-cyclohex
CAS No.14328-51-9
PubChem CID736848

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACWMHB495 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCZIU451 route compound structure diagram
    ACCZIU451563-67-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACWMHB495 route product structure diagram
    ACWMHB49514328-51-9 In Stock
Inquiry

2. ACWMHB495 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCWFM015 route compound structure diagram
    ACCWFM015760-84-9 In Stock
  2. Plus
  3. ACEDMW612 route compound structure diagram
    ACEDMW6126108-23-2 In Stock
  4. Plus
  5. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  6. Then
  7. ACWMHB495 route product structure diagram
    ACWMHB49514328-51-9 In Stock
Inquiry

Comments (0)